Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

10x Genomics (TXG) Return on Assets (2019 - 2026)

10x Genomics' Return on Assets history spans 7 years, with the latest figure at 0.0% for Q4 2025.

  • On a quarterly basis, Return on Assets changed 0.0% to 0.0% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.0%, a 0.0% change, with the full-year FY2025 number at 0.0%, changed 0.0% from a year prior.
  • Return on Assets hit 0.0% in Q4 2025 for 10x Genomics, up from 0.0% in the prior quarter.
  • Over the last five years, Return on Assets for TXG hit a ceiling of 0.0% in Q4 2025 and a floor of 0.01% in Q1 2021.
  • Historically, Return on Assets has averaged 0.0% across 5 years, with a median of 0.0% in 2025.
  • The widest YoY moves for Return on Assets: up 0bps in 2021, down 0bps in 2021.
  • Tracing TXG's Return on Assets over 5 years: stood at 0.0% in 2021, then crashed by -183bps to 0.0% in 2022, then crashed by -63bps to 0.0% in 2023, then increased by 26bps to 0.0% in 2024, then soared by 79bps to 0.0% in 2025.
  • Business Quant data shows Return on Assets for TXG at 0.0% in Q4 2025, 0.0% in Q3 2025, and 0.0% in Q2 2025.